Regulus Therapeutics Reports First Quarter 2023 Financial Results and Recent Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Regulus Therapeutics (RGLS) Tops Q1 EPS by 3c
May 11, 2023 4:50 PM EDTRegulus Therapeutics (NASDAQ: RGLS) reported Q1 EPS of ($0.42), $0.03 better than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Regulus Therapeutics (RGLS) click here.
... More